01 8Meropen
02 2Merrem/Meronem
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2020 Revenue in Millions : 287
2019 Revenue in Millions : 213
Growth (%) : 35
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2021 Revenue in Millions : 295
2020 Revenue in Millions : 287
Growth (%) : 17
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2022 Revenue in Millions : 301
2021 Revenue in Millions : 295
Growth (%) : 2
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2023 Revenue in Millions : 174
2022 Revenue in Millions : 323
Growth (%) : -39
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2015 Revenue in Millions : 253
2014 Revenue in Millions : 0
Growth (%) : -100%
Main Therapeutic Indication : Neuroscience and Mental Health
Currency : USD
2014 Revenue in Millions : -13.70%
2013 Revenue in Millions :
Growth (%) :
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2016 Revenue in Millions : 245
2015 Revenue in Millions : 256
Growth (%) : -4
Main Therapeutic Indication : Anti-bacterial
Currency : USD
2017 Revenue in Millions : 290
2016 Revenue in Millions : 258
Growth (%) : 12
Main Therapeutic Indication : Anti-Bacterial
Currency : USD
2018 Revenue in Millions : 131
2017 Revenue in Millions : 30
Growth (%) : 339%
Main Therapeutic Indication : Infectious Diseases
Currency : USD
2019 Revenue in Millions : 206
2018 Revenue in Millions : 135
Growth (%) : 52
